Vera Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Vera Therapeutics, Inc. (VERA) reported Basic Shares Outstanding (Weighted Average) of 71.84 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- Vera Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 71.84M shares, a 12.62% increase year-over-year.
- Vera Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 71.48M shares, a 12.26% increase year-over-year.
- Vera Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 65.63M shares, a 8.13% increase year-over-year.
- Vera Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 63.85M shares, a 16.30% increase year-over-year.
- Vera Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 64.23M shares, a 16.10% increase from fiscal 2024.
- Vera Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 55.33M shares, a 29.55% increase from fiscal 2023.
- Vera Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 42.71M shares, a 60.73% increase from fiscal 2022.
- Vera Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 26.57M shares, a 97.76% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 71.84M shares 10-Q · filed 2026-08-10 | 71.66M shares 10-Q · filed 2026-08-10 | 69.65M shares derived: average of 3 quarters · filed 2026-08-10 | 68.20M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 71.48M shares 10-Q · filed 2026-05-07 | 68.55M shares derived: average of 2 quarters · filed 2026-05-07 | 66.98M shares derived: average of 3 quarters · filed 2026-05-07 | 66.18M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 65.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 64.74M shares derived: average of 2 quarters · filed 2026-02-26 | 64.42M shares derived: average of 3 quarters · filed 2026-08-10 | 64.23M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 63.85M shares 10-Q · filed 2025-11-05 | 63.82M shares derived: average of 2 quarters · filed 2026-08-10 | 63.77M shares 10-Q · filed 2025-11-05 | 63.00M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 63.79M shares 10-Q · filed 2026-08-10 | 63.73M shares 10-Q · filed 2026-08-10 | 62.72M shares derived: average of 3 quarters · filed 2026-08-10 | 60.76M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 63.67M shares 10-Q · filed 2026-05-07 | 62.18M shares derived: average of 2 quarters · filed 2026-05-07 | 59.75M shares derived: average of 3 quarters · filed 2026-05-07 | 58.50M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 60.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 57.80M shares derived: average of 2 quarters · filed 2026-02-26 | 56.77M shares derived: average of 3 quarters · filed 2026-02-26 | 55.33M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 54.90M shares 10-Q · filed 2025-11-05 | 54.81M shares derived: average of 2 quarters · filed 2025-11-05 | 53.54M shares 10-Q · filed 2025-11-05 | 51.26M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 54.73M shares 10-Q · filed 2025-08-05 | 52.85M shares 10-Q · filed 2025-08-05 | 50.05M shares derived: average of 3 quarters · filed 2026-02-26 | 48.63M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 50.97M shares 10-Q · filed 2025-05-07 | 47.71M shares derived: average of 2 quarters · filed 2026-02-26 | 46.60M shares derived: average of 3 quarters · filed 2026-02-26 | 46.01M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 44.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 44.41M shares derived: average of 2 quarters · filed 2026-02-26 | 44.36M shares derived: average of 3 quarters · filed 2026-02-26 | 42.71M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 44.36M shares 10-Q · filed 2024-11-07 | 44.32M shares derived: average of 2 quarters · filed 2024-11-07 | 42.12M shares 10-Q · filed 2024-11-07 | 38.51M shares derived: average of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | 44.27M shares 10-Q · filed 2024-08-08 | 40.99M shares 10-Q · filed 2024-08-08 | 36.56M shares derived: average of 3 quarters · filed 2024-08-08 | 34.22M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 37.67M shares 10-Q · filed 2024-05-10 | 32.70M shares derived: average of 2 quarters · filed 2024-05-10 | 30.87M shares derived: average of 3 quarters · filed 2024-05-10 | 29.92M shares derived: average of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | 27.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 27.47M shares derived: average of 2 quarters · filed 2024-03-27 | 27.34M shares derived: average of 3 quarters · filed 2024-03-27 | 26.57M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 27.22M shares 10-Q · filed 2023-11-09 | 27.15M shares derived: average of 2 quarters · filed 2023-11-09 | 26.18M shares 10-Q · filed 2023-11-09 | 24.97M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 27.08M shares 10-Q · filed 2023-08-10 | 25.66M shares 10-Q · filed 2023-08-10 | 24.22M shares derived: average of 3 quarters · filed 2023-08-10 | 23.48M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 24.23M shares 10-Q · filed 2023-05-11 | 22.79M shares derived: average of 2 quarters · filed 2023-05-11 | 22.29M shares derived: average of 3 quarters · filed 2023-05-11 | 19.34M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 21.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | 21.31M shares derived: average of 2 quarters · filed 2023-03-28 | 17.71M shares derived: average of 3 quarters · filed 2023-03-28 | 13.44M shares 10-K · filed 2023-03-28 |
| 2021-09-30 | 21.27M shares 10-Q · filed 2022-11-09 | 15.88M shares derived: average of 2 quarters · filed 2022-11-09 | 10.79M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 10.50M shares 10-Q · filed 2022-08-10 | 5.47M shares 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |